WCO classification path
- Chapter30Pharmaceutical products
- Heading3004Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (iincluding those in the form of transdermal administration systems) or in forms or packings for retail sale
- Subheading300460Other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter
- National30046000Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter
30046000
"Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter"
HS code 3004600000 (Chapter 30 "Pharmaceutical products"; Heading 3004 "Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (iincluding those in the form of transdermal administration systems) or in forms or packings for retail sale"; Subheading 300460 "Other, containing antimalarial active principles described in Sub-heading Note 2 to this Chapter") under the Korea tariff schedule classifies "Other, containing antimalarial active principles described in Subheading Note 2 to this Chapter". Korea customs apply MFN rate of 8, WTO bound rate 0. Statutory unit of measure: KG. This commodity is subject to 3 import regulations or restrictions; see compliance section below. 30 free trade agreement preferential rates are available for this code.
Tariff Schedule
| Classification | Rate |
|---|---|
MFN 税率 MFN rate | 8 |
WTO 约束税率 WTO bound rate | 0 |
FTA Preferential Rates
30 agreements available · certificate of origin required
| Agreement | Rate |
|---|---|
| AKFTA (ASEAN-Korea) | 0% |
| KAFTA (Korea-Australia) | 0% |
| CKFTA (Canada-Korea) / CPTPP | 0% |
| Korea-Central America (Costa Rica) | 0% |
| Korea-Central America (Honduras) | 0% |
| Korea-Central America (Nicaragua) | 0% |
| Korea-Central America (Panama) | 0% |
| Korea-Central America (El Salvador) | 0% |
| Korea-Chile | 0% |
| Korea-China | 0% |
| Korea-Colombia | 0% |
| Korea-EFTA | 0% |
| Korea-EU | 0% |
| Korea-UK | 0% |
| Korea-Indonesia (CEPA) | 0% |
| Korea-Israel | 0% |
| Korea-India (CEPA) | 0% |
| Korea-Cambodia | 0% |
| Korea-New Zealand | 0% |
| Korea-Peru | 0% |
| Korea-Philippines | 0% |
| Korea-Turkey | 0% |
| KORUS (Korea-US) | 0% |
| Korea-Vietnam | 0% |
| RCEP | 0% |
| RCEP (ASEAN) | 4% |
| RCEP (Australia) | 4% |
| RCEP (China) | 4% |
| RCEP (Japan) | 4% |
| RCEP (New Zealand) | 4% |
Compliance & Controls
3 import regulations, restrictions, or permit requirements
마약류 관리에 관한 법률
마약류수입승인서
의료기기법
표준통관예정보고서(의료기기)
약사법
표준통관예정보고서(의약품등)
Global Benchmark
HS-6 prefix 3004.60 across other jurisdictions